Biology Reference
In-Depth Information
49. Olsson RA, Pearson JD. (1990) Cardiovascular purinoceptors. Physiol Rev 70:761-845.
50. Plank M, Wall D, David T. (2006) Atherosclerosis and calcium signalling in endothelial cells.
Prog Biophys Mol Biol 91:287-313.
51. Ralevic V, Burnstock G. (1991) Roles of P2-purinoceptors in the cardiovascular system.
Circulation 84:1-14.
52. Ralevic V, Burnstock G. (1998) Receptors for purines and pyrimidines. Pharmacol Rev
50:413-92.
53. Roberts VH, Webster RP, Brockman DE, Pitzer BA, Myatt L. (2006) Post-Translational
Modifications of the P2X(4) Purinergic Receptor Subtype in the Human Placenta are Altered
in Preeclampsia. Placenta.
54. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW,
Bach FH. (1997) Loss of ATP diphosphohydrolase activity with endothelial cell activation.
J Exp Med 185:153-63.
55. Rosenmeier JB, Hansen J, Gonzalez-Alonso J. (2004) Circulating ATP-induced vasodilata-
tion overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558:
351-65.
56. Rosenmeier JB, Yegutkin GG, Gonzalez-Alonso J. (2008) Activation of ATP/UTP-selective
receptors increases blood flow and blunts sympathetic vasoconstriction in human skeletal
muscle. J Physiol 586:4993-5002.
57. Saito D, Steinhart CR, Nixon DG, Olsson RA. (1981) Intracoronary adenosine deaminase
reduces canine myocardial reactive hyperemia. Circ Res 49:1262-7.
58. Schluter H, Offers E, Bruggemann G, van der Giet M, Tepel M, Nordhoff E, Karas M,
Spieker C, Witzel H, Zidek W. (1994) Diadenosine phosphates and the physiological control
of blood pressure. Nature 367:186-8.
59. Skals M, Jorgensen NR, Leipziger J, Praetorius HA. (2009) Alpha-hemolysin from
Escherichia coli uses endogenous amplification through P2X receptor activation to induce
hemolysis. Proc Natl Acad Sci USA 106:4030-5.
60. Sluyter R, Shemon AN, Barden JA, Wiley JS. (2004) Extracellular ATP increases cation
fluxes in human erythrocytes by activation of the P2X7 receptor. J Biol Chem 279:
44749-55.
61. Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. (1995) Endothelial
release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation
92:2135-41.
62. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. (2001) Participation of cAMP in a
signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol
Cell Physiol 281:C1158-64.
63. Sprague RS, Olearczyk JJ, Spence DM, Stephenson AH, Sprung RW, Lonigro AJ. (2003)
Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular
resistance. Am J Physiol Heart Circ Physiol 285:H693-700.
64. Sprague RS, Stephenson AH, Ellsworth ML, Keller C, Lonigro AJ. (2001) Impaired release
of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med
(Maywood) 226:434-9.
65. Tanneur V, Duranton C, Brand VB, Sandu CD, Akkaya C, Kasinathan RS, Gachet C,
Sluyter R, Barden JA, Wiley JS, Lang F, Huber SM. (2006) Purinoceptors are involved in the
induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes.
Faseb J 20:133-5.
66. Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, Bjur RA,
Westfall DP. (1997) Neuronal release of soluble nucleotidases and their role in neurotrans-
mitter inactivation. Nature 387:76-9.
67. Tolle M, Jankowski V, Schuchardt M, Wiedon A, Huang T, Hub F, Kowalska J, Jemielity J,
Guranowski A, Loddenkemper C, Zidek W, Jankowski J, van der Giet M. (2008) Adenosine
5
-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor. Circ Res
103:1100-8.
Search WWH ::
Custom Search